Sildenafil (Viagra) for the Treatment of Erectile Dysfunction in Men With Diabetes

1. Feldman HA , Goldstein I , Hatzichristou DG , Krane RJ , McKinlay JB . Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.

2. Price DE , O'Malley BP , James MA , et al. Why are impotent diabetic men not being treated? Practical Diabetes. 1991;8:10-11.

3. Fairburn CG , McCulloch DK , Wu FC . The effects of diabetes on male sexual function. Clin Endocrinol Metab. 1982;11:749-767.

4. National Institutes of Health . Consensus development panel on impotence. JAMA. 1993;280:83-90.

5. Boolell M , Gepi-Attee S , Gingell JC , Allen MJ . Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 1996;78:257-261.

6. Goldstein I , Lue TF , Padma-Nathan H , Rosen RC , Steers WD , Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338:1397-1404.

7. Guyton AC , Hall JE . Reproductive and hormonal functions of the male and the pineal gland. In: Textbook of Medical Physiology. 9th ed. Philadelphia, Penn: WB Saunders;1996:1008-1009.

8. Bancroft J , Gutierrez P . Erectile dysfunction in men with and without diabetes mellitus: a comparative study. Diabetic Med. 1996;13:84-89.

9. Chaudhuri A , Wiles P . Optimal treatment of erectile failure in patients with diabetes. Drugs. 1995;49:548-554.

10. Bush PA , Aronson WJ , Raifer J , Ignarro W . The L-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory non-adrenergicnon-cholinergic neurotransmission in the corpus cavernosum of human and rabbit. Circulation. 1993;87(suppl v):V30-V32.

11. Terrett NK , Bell AS , Brown D , Ellis P . Sildenafil (Viagra) a potent and selective inhibitor of type 5 CGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorganic Med Chem Lett. 1996;6:1819-1824.

12. Soderdahl DW , Thrasher JB , Hansberry KL . Intracavernosal druginduced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Br J Urol. 1997;79:952-957.

13. Chew KK , Stuckey BG , Earle CM , Dhaliwal SS , Keogh EJ . Penile fibrosis in intracavernosal prostaglandin El injection therapy for erectile dysfunction. Int J Impotence Res. 1997;9:225-229.

14. Sildenafil citrate (Viagra) [package insert]. New York, NY: Pfizer Labs; 1998.

15. Boolell M , Allen MJ , Ballard SA , et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impotence Res. 1996;8:47-52.

16. Food and Drug Administration . Joint clinical review for NDA-20-895, sildenafil (Viagra), 1998. Rockville, Md: Food and Drug Administration, Center for Drug Evaluation and Research; 1998.

Allawi J . Impotence in the diabetic patient. Practitioner. 1997;241:265-270.

Becker AJ , Stief CG , Machtens S , et al. Oral phentolamine as treatment for erectile dysfunction. J Urol. 1998;159:1214-1216.